ArticleBlood advances2026

Immunogenicity and safety of a third and subsequent COVID-19 vaccine doses in patients with plasma cell dyscrasias.

Sita Bhella et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.